The majority of the colon cancers analyzed to-date express insulinlike growth factor binding protein (IGFBP)-4, and antisense inhibition of IGFBP-4 messenger RNA (mRNA) confers a growth advantage to the cells in response to endogenous and exogenous IGFs. We recently reported a significant up-regulation of IGFBP-4 expression in a human colon cancer cell line (CaCo2) on spontaneous differentiation of the cells in culture. This suggests that the expression of IGFBP-4 may be related to growth and differentiation of colon cancer cells. To study the endogenous factors involved in the transcriptional regulation of IGFBP-4, we have isolated and sequenced the human (h) IGFBP-4 promoter. The approximately 1.3 kilobase pair (kb) 5Ј flanking region of the IGFBP-4 gene is GC rich and possesses several potential regulatory elements. These elements include a typical TATA box with sequence TATAA, located Ϫ299 nt from the initiation ATG codon. The cap site is located 14 nt downstream of the TATA box as determined by primer extension analysis. A 1.4-kb DNA fragment including the 1.254 kb 5Ј flanking region of the hIGFBP-4 gene was subcloned into a luciferase reporter vector (pGL-2 basic) either in the sense (BP-4-S-pGL) (S) or antisense (BP-4-AS-pGL) (AS) (negative control) orientation, relative to the luciferase coding sequence in the vector. CaCo2 cells were transfected with either the S or the AS vectors on days 2-10 of culture; cotransfection with the SV40-␤-Galactidose (Gal) vector was used to correct for transfection efficiency. The ratio of luciferase/␤-Gal expression by CaCo2 cells transfected with the S vectors increased significantly from days 3 and 4 to days 5 and 6 of culture, followed by a sharp decline on days 7-9, resembling the pattern of endogenous expression of IGFBP-4 by the cells; the expression of luciferase by the AS vectors remained low and insignificant. These results thus suggest that the approximately 1.4 kb 5Ј flanking region of the IGFBP-4 gene contains the cis elements required for regulation of the IGFBP-4 gene. Cloning and sequencing of the functional hIGFBP-4 promoter will enable us, for the first time, to study the endogenous factors/mechanisms responsible for the growth/differentiation (cell density) associated regulation of IGFBP-4 expression in colonic epithelial cells. (Endocrinology 138: 332-343, 1997) 
A
T LEAST SIX insulin-like growth factors (IGFBPs) have been identified and their complementary DNAs (cDNAs) cloned from several species (1) . Of the six IGFBPs identified to-date, most human colon cancers express IG-FBP-2 and IGFBP-4; less than 50% also express IGFBP-3, IGFBP-5, and/or IGFBP-6 and none express IGFBP-1 (2) . We now know that IGFBPs play an important role in modulating the mitogenic effects of insulin-like growth factors (IGFs) that are available to the cells by endocrine/paracrine/autocrine routes (3, 4) . In recent years, both inhibitory and stimulatory effects of IGFBP proteins have been reported (4 -15) . The inhibitory effects have been attributed primarily to competitive scavenging of the IGFs away from the IGF-I receptors (3, 4, 9 -11) . The stimulatory effects are less well understood. Significant potentiation of IGF effects by IGFBP-3 and IG-FBP-5 have been reported on specific cell types under certain cell culture conditions (4, 6, (12) (13) (14) . Besides IGF-dependent effects, IGF-independent effects of some binding proteins have also been reported in recent years (6, 11, 12, 15, 16) . Based on our studies so far, it appears that IGFBP-4 primarily functions as an inhibitory protein for colon cancer cells (2, 3, 11, 17) . We recently reported that differential expression of IGF-II and IGFBP-4 plays an important role in the proliferation and differentiation of a human colon cancer cell line (CaCo2) that undergoes spontaneous enterocytic differentiation in culture; the differentiation of the cells required an attenuation of IGF-II effects (17) . The attenuation was apparently achieved by significant down-regulation of IGF-II expression accompanied by a significant up-regulation of IGFBP-4 messenger RNA (mRNA) expression, which may have provided the initial signal for the onset of differentiation of the cells in culture (17) . It thus appears likely that transcriptional regulation of IGFBP-4 in colon cancer cells may provide an important mechanism by which the proliferative and differentiation potential of the cells, in response to the endogenous mitogen, is further fine-tuned and modulated. While the human IGF-II promoter is cloned and is currently being characterized by several laboratories (18, 19) , the functional promoter for the human (h) IGFBP-4 gene has yet to be characterized. Endogenous factors that may be involved in the differential regulation of the IGFBP-4 expression therefore remain to be characterized. The present study was undertaken to clone and sequence the functional promoter for the hIGFBP-4 gene, which would then help us to characterize the endogenous factors involved in the growth and differentiation of colonocytes via the IGF system. In the present study, we report the cloning and sequencing of approximately 1.4 kilobase pairs (kb) of the promoter sequence, 5Ј of the start codon, that apparently contains all the cis elements required for regulation of IGFBP-4 expression in a cell density (growth vs. differentiation)-dependent manner in CaCo2 cells.
Material and Methods

Isolation of the 5Ј flanking region of the human (h) IGFBP-4 gene
A human genomic library in the bacteriophage P1 vector was screened by PCR (20) by Genome Systems, Inc. (St. Louis, MO). The PCR primers used for screening were the sense (GCCGACCTGGGCGAC-GAAGCCATCCACTG) and antisense (TTGCCCGTGCATCAGTGTGT-GCAGGGGCTT) primers, specific for the hIGFBP-4 cDNA (21) . Three positive clones (C1-C3) were isolated containing approximately 100 kb inserts which were amplified and confirmed to be positive by Southern hybridization with a 505-bp hIGFBP-4 cDNA fragment (position: ϩ211 to ϩ716 from the ATG codon of hIGFBP-4 cDNA, released by EcoRI and HindIII from plasmid pHBP4-503, obtained from Dr. S. Shimasaki). The fragment was labeled using Nick-Translation System from Life Technology (Gaithersburg, MD). The C1-C3 clones were also positive by Southern hybridization with 32 P-dCTP labeled PCR product (235 bp) corresponding to nucleotides ϩ50 to ϩ290 (relative to the ATG initiation codon) of the hIGFBP-4 cDNA (amplified with primers used for screening purposes as described above). The inserts from the three positive clones were then further digested with the restriction endonucleases, BamH-I and Hind-III (Promega, Madison, WI), as recommended by the supplier. The digests were separated on a 0.7% agarose gel and transferred to a modified nylon-66 membrane (Schleicher & Schuell, Keene, NH) as suggested by the manufacturer. The 235-bp PCR product (as described above) was labeled with 32 P-dCTP by Nick translation and used as a probe for Southern hybridization. The nylon filters were incubated in 50% formamide, containing 6 ϫ SSPE, 0.5% SDS, 50 g/ml low mol wt denatured DNA, at 42 C overnight. The filters were washed twice with 6 ϫ SSPE/0.2% SDS at room temperature for 15 min and twice with 1 ϫ SSPE/0.2% SDS at 37 C for 15 min and finally soaked in 0.1 ϫ SSPE/1% SDS at 65 C for 30 min. The filters were exposed to x-ray films at Ϫ80 C overnight. Positive fragments (Fig. 1 ) from the digestions were further purified from the agarose gel using QIAquick gene extraction kits (Qiagen Inc., Chatsworth, CA) as per the protocol provided by the company. The positive fragments which contained the 5Ј sequences for the hIGFBP-4 cDNA were then subcloned into pBluescript II SK ϩ (Stratagene Cloning Systems, La Jolla, CA) vectors for sequencing.
DNA sequencing
The Bluescript vectors containing the 5 and 7 kb DNA fragments (pB-5BP4 and pB-7BP4) (positive for the 5Ј hIGFBP-4 cDNA) (Fig. 1) were subjected to DNA sequencing essentially by the method of Sanger et al. (22) using the Quick-denatured plasmid sequence kit (Amersham Life Sciences, Arlington Heights, IL), as per the protocols provided by the company. Several sets of 5Ј and 3Ј oligonucleotide sequences were used, which corresponded to the sequences within the 5Ј region of the hIG-FBP-4 cDNA and within the 5Ј flanking region of the hIGFBP-4 gene. Both strands of the promoter DNA were subjected to sequencing for purposes of confirming the nucleotide sequence of the 1.4-kb promoter fragment.
Primer extension analysis
A synthetic 18-bp oligonucleotide (5Ј-ACGTAGCGGGGGAAGTTA-3Ј) that was complementary to nucleotides 134 to 151 downstream from the TATA box of the human IGFBP-4 gene was used for primer extension analysis. The primer was 5Ј end-labeled with 32 P-ATP using bacteriophage T 4 polynucleotide kinase. Primer extension analysis was conducted using 5 g poly-A ϩ RNA from a human colon cancer cell line (Colo-205) (which is known to express high concentrations of IGFBP-4) (2), with the AMV reverse transcriptase primer extension system obtained from Promega as per the protocols provided by the company. Briefly, 100 fmol labeled oligonucleotide was annealed to poly-A ϩ RNA in primer extension buffer (50 mm Tris-HCl, pH 8.3; 50 mm KCl; 10 mm MgCl 2 ; 10 mm DTT; 1 mm of each dNTP; 0.5 mm spermidine) at 58 C for 20 min and cooled at room temperature for 10 min. The primer was next extended with 10 U AMV reverse transcriptase at 42 C for 30 min in primer extension buffer. The reaction (Rx) products were separated by electrophoresis on a 6% polyacrylamide-8 m urea sequencing gel in parallel with a sequencing Rx using the same primer to determine the CAP site (the initiation site for the transcription of human IGFBP-4 mRNA). Poly-A ϩ RNA was prepared from total RNA of Colo-205 cells by a single step guanidine thiocyanate method with the help of a kit purchased from Qiagen (Chatsworth, CA). The concentration of poly-A ϩ RNA was quantified by absorbance at 260 nm. The purity of poly-A ϩ RNA was assessed after fractionating an aliquot on 1% formaldehyde-agarose gels followed by ethidium bromide staining. Absence of 28S and 18S RNA bands was taken as a measure of the purity of poly-A ϩ RNA prepared.
Construction of human IGFBP-4-luc expression vector for transfections
To determine the promoter activity of the 5Ј flanking fragment of the human IGFBP-4 gene, an approximately 1.4-kb DNA fragment was fused to the luciferase reporter gene, as diagramatically presented in Fig.  2 . Briefly, the 1.467-kb DNA fragment was amplified by PCR from the pB-7BP4 Bluescript vector (described above), using the 5Ј sense primer 5Ј-TCACCGTGCTAGCAGGATGGT-3Ј (BP4-1) (nt Ϫ1250 to Ϫ1230) and the 3Ј antisense primer 5Ј-AGGGCACACGGCGGCAG CGCT-3Ј (BP4-2) (nt ϩ196 to ϩ216). The PCR Rx was performed in the presence of AmpliTaq DNA Polymerase (Perkin Elmer Corp., Foster City, CA) as described previously (23) . The PCR product was subcloned into the PCR-II vector using the TA-cloning kit (Invitrogen, San Diego, CA) as the per the protocols provided by the supplier. The approximately 1.4-kb DNA fragment was released from the PCR II vector either by KpnI and XhoI or by HindIII and Xho-I endonucleases. Both DNA fragments were subcloned into the promoterless luciferase reporter vector, pGL2-basic (Promega), predigested with either KpnI and XhoI or with HindIII and XhoI, in either the sense (BP-4-S-pGL) (S) or the antisense (BP-4-AS-pGL) (AS) orientation, relative to the luciferase codon sequence, respectively. The S and AS vectors were confirmed by DNA sequencing using pGL Primer-1, 5Ј-TCTATCTTATCCTACTGTAACTG-3Ј (ϳ10 bp upstream from multiple cloning site of pGL-2 basic vector) and pGL primer-2, 5Ј-CTTTATGTTTTTGGCGTCTTCC-3Ј (ϳ20 bp downstream from multiple cloning site of pGL-2 basic vector).
FIG. 1.
Isolation of DNA fragments containing 5Ј flanking region of the human IGFBP-4 gene. A human genomic library in the bacteriophage PI vector was screened by PCR using primers for human IG-FBP-4 that were close to the 5Ј end of human IGFBP-4 cDNA (near the ATG codon), described in Materials and Methods. Three positive clones, C1, C2, and C3 were isolated, which contained 100-kb inserts and were confirmed by Southern hybridization using a human IG-FBP-4 cDNA probe, as described in Materials and Methods. Clones C1, C2, and C3 were digested with BamH-I and C2 was digested with Hind-III and subjected to Southern hybridization with a human IG-FBP-4 cDNA probe, and the results are shown in the figure. DNA fragments BI (5 kb) and HI (7 kb) from C2 digests were subcloned into pBluescript II SK ϩ vectors and designated HGBP-4A and HGBP-4B and used further for sequencing purposes.
DNA transfection of CaCo2 cells
CaCo2 cells were obtained from Dr. Jing Yu, Tufts School of Medicine (Boston, MA). The cells were grown as monolayer cultures in humidified atmosphere of 95% air/5% CO 2 in high glucose (25 mm) DMEM supplemented with 2 mm glutamine, 1 mm sodium pyruvate and 10% heat-inactivated FCS (Hyclone, Logan, UT), at 37 C. The cells were monitored regularly for mycoplasma contamination using the Mycoplasma PCRELISA kit from Boehringer Mannheim (Indianapolis, IN). Stock cultures of the cells were subcultured at appropriate intervals to maintain the cells at subconfluent densities. For cell counting and subculturing, the cells were dispersed with a solution of 0.05% trypsin and 0.02% EDTA. To conduct the transfection studies in relation to proliferation and differentiation of the cells, the CaCo2 cells were plated at a density of 3 ϫ 10 5 cells/35 mm cell culture plate and transfected with 1-10 g of either the S or the AS DNA (described above), on days 2-10 of cell culture. Cells were cotransfected with the SV40 ␤-Galactosidose (Gal) expression vector (pSV-␤-Gal vector, Promega) to normalize our results for efficiency of transfection on different days of culture. Duplicate wells were transfected with 1-10 g of luciferase expression vector (pGL2, Promega) under the transcriptional control of the SV40 promoter, as a positive control. In previous studies, we have reported that under the cell culture conditions of the present study, CaCo2 cells demonstrate an initial rapid phase of growth between days 2-7 of culture followed by a significant retardation of growth between days 7-13 (17) . Alkaline phosphatase activity, used as a marker of enterocytic differentiation (24) , on the other hand, is expressed at very low levels between days 2 and 7 and progressively increases between days 7 and 13 in culture, correlating with postconfluent phase of negligible growth (17) . In the same study, we observed that the relative mRNA concentrations of IGFBP-4 increased rapidly by days 5-7 to approximately 200% of day 2 values and returned to baseline levels by days 9 -13 (17) . We therefore chose days 3-6 as representative of cells in the proliferative phase with minimal differentiation and days 7-9 as representative of cells undergoing rapid differentiation, with minimal growth. Cells were grown in regular growth medium containing 10% FCS until 22 h before transfection. Fresh growth medium containing 10% FCS was added on alternate days until the day of transfection. Additionally, before transfection, fresh growth medium containing 10% FCS was added. Cells were transfected with 1-10 g of either the S or the AS vector DNA by the Ca ϩϩ phosphate precipitation method as described previously (11) . Post transfection, the cells were washed with fresh medium containing 10% FCS and cells cultured for 24 h followed by cell lysis for purposes of measuring luciferase and ␤-Gal activities as described below. Duplicate wells seeded similarly and grown under similar conditions were processed for RNA extraction for purposes of measuring relative concentrations of IGFBP-4 mRNA by RT-PCR, as described below. Within the same experiment, a set of plates was set up similarly, and the total number of cells in each plate counted on the day of harvest to confirm the growth pattern of the cells.
Luciferase and ␤-Gal assays
Cells were washed twice with PBS and lysed using the reporter lysis buffer (Promega) as per the protocols provided by the company. Lysis buffer (200 l) was used for each 35-mm dish. The cellular debris were pelleted and the supernatant saved for analysis of luciferase and ␤-Gal activities. Luciferase activity was measured with the Luciferase Assay System (Promega), using 20 l cell extract and 100 l luciferase assay buffer (20 mm 
RT-PCR analysis of IGFBP-4 mRNA levels in CaCo2 cells
Duplicate 35-mm dishes containing CaCo2 cells that were in culture for days 3-9 under conditions similar to that described above for measuring luciferase activity were processed for RNA extraction by a singlestep guanidine thiocyanate method (25) . cDNA was prepared from 1 g total RNA from triplicate dishes at each time point using 10 units AMV reverse transcriptase (Promega) in 5 mm MgCl 2 , 10 mm Tris-HCl; 50 mm KCl, 0.1% Triton X-100, 0.5 g poly-(dT) 15 , 1 U/l rRNasin, 1 mm each dNTP, at 42 C for 30 min. Ten % of cDNA made from 1 g total RNA was used for amplification by PCR, using 15-32 PCR cycles. The primers used for amplification included the sense primer, 5Ј-TGCAGAAG-CACTTCGCCAAA-3Ј (representing nt ϩ700 to ϩ720; 416 to 436 nt downstream from the ATG codon of human IGFBP-4 cDNA) and antisense primer 5Ј-ACAGGACTCAGACTCAGACT-3Ј (representing nt ϩ1130 to ϩ1150; 852 bp to 872 bp downstream from ATG codon of human IGFBP-4 cDNA). To detect the PCR products (especially those that were amplified for Ͻ30 cycles), the PCR reaction was performed in 50 l buffer containing 2 l cDNA, 20 pmol of each primer, 250 m dNTPs, 2 Ci ␣-32 P dCTP (Ն3000Ci/mmol) 10 mm Tris-HCl, pH 9.0, 50 mm KCl, 0.01% gelatin, 2.0 mm MgCl 2 , 0.3 units Taq polymerase. The reactions were denatured at 94 C for 30 sec, annealed at 60 C for 45 sec, and elongated at 72 C for 1 min/cycle. Twenty microliters of mixture from each reaction were then electrophoresed on 1% agarose and transferred to Nytran membranes. The membranes were air dried and exposed to x-ray film at Ϫ80 C overnight. In a second set of experiments, cDNA equivalent to 1 g total RNA from each duplicate dish as described above was subjected to PCR for 32 cycles using the same primer set and under similar conditions but in the absence of radiolabeled nucleotides. The reaction products were detected by ethidium bromide staining of the agarose gels. The relative concentrations of IGFBP-4 mRNA were then determined by densitometric analysis of either the autoradiographs (of samples amplified in the presence of radiolabeled nucleotides) or of the photographs of ethidium bromide stained reaction products. The densitometric analysis was done with the help of Ultrascan XL Enhanced Laser Densitometer and the GelScan software (Pharmacia, Piscataway, NJ).
Results
Isolation of the 5Ј flanking region of the human IGFBP-4 gene
A human genomic library in the bactrophage P1 vector was screened by PCR by Genome Systems, Inc. as described in Materials and Methods. Genome Systems provided us with three positive clones (C1-C3) containing approximately 100-kb inserts. The three inserts were digested with the restriction endonuclease, BamH-I, and the digests electrophoretically separated on 0.7% agarose gels and transferred to nylon membranes. The membranes were subjected to Southern hybridization with a 240-bp radiolabeled hIGFBP-4 cDNA fragment, and a representative autoradiogram is shown in Fig. 1 . BamH-I digests of all the three clones demonstrated the presence of a positive 5-kb fragment. The C2 clone was also digested with HindIII, and the digest was similarly subjected to Southern hybridization. The HindIII fragment of the C2 clone demonstrated the presence of a positive 7-kb fragment (Fig. 1) . We arbitrarily chose the 5 kb BamH-I fragment and the 7-kb Hind-III fragment of the C2 clone for subcloning into the pBluescript II SK ϩ vector for sequencing purposes.
Determination of the start site of transcription
The transcription initiation site was determined by primer extension analysis as described in Materials and Methods. The primer extension experiments revealed three bands of sizes 124, 129, and 134 nucleotides in length, of which the band sized approximately 135 nucleotides was the most prominent (Fig. 3) . Based on the fact that we used an oligonucleotide primer complementary to nucleotides 129 -146 downstream from the TATA box of the human IGFBP-4 gene for primer extension analysis, it is predicted that the major start site of transcription is approximately 13-bp downstream from the TATA box of the hIGFBP-4 gene (Fig. 3) . We have so far determined the start site of transcription for only human colon cancer cell lines. Representative data from one human colon cancer cell line, Colo-205, is shown in Fig. 3 . Primer extension analysis with two other human colon cancer cell lines, CaCo2 and HT-29, gave similar results (data not shown).
Analysis of the human IGFBP-4 promoter
The bluescript vectors containing the 5 and 7 kb DNA fragments (pB-5B P4 and pB-7B P4) (positive for the 5Ј hIG-FBP-4 cDNA) were subjected to DNA sequencing as described in Materials and Methods, and the partial sequence obtained is presented in Fig. 4A . A consensus TATA box sequence with the sequence TATAA, 14 nt 5Ј to the start site of transcription, was identified ( Table 1 ). The 5Ј nucleotide sequence of the rat IGFBP-4 gene (26) was compared with the human IGFBP-4 gene sequenced by us (Fig. 4B) . The two sequences demonstrated 74% homology between Ϫ631 and ϩ286 nt, relative to the cap site. A number of consensus sequences were identified within the approximately 1400 bases of the human IGFBP-4 5Ј flanking promoter region as shown in Table 1 . These included a potential ATF/CREB site (Ϫ1169 to Ϫ1161) and an API site (Ϫ866 to Ϫ859) relative to the CAP site. Three sequences (Ϫ562/Ϫ554; ϩ288/ϩ235; ϩ261/ϩ269) closely matching the early growth response factor I binding sites were also identified. Potential SPI binding sites were found in the CG-rich region of the promoter sequence (ϩ50 to Ϫ100 nucleotides). Strong et al. have sequenced 396 nucleotide bases of the human IGFBP-4 5Ј flanking region (as reported to the Genebank, accession no. 4U20982), which bears 99% homology with the corresponding sequence identified by our laboratory.
To determine if the 1,254-bp putative promoter fragment of the human IGFBP-4 gene was functional, a 1.4-kb fragment (Ϫ1250 bp to ϩ217 bp of the hIGFBP-4 gene) (containing the start site of transcription and the TATA box) was inserted 5Ј to the luciferase reporter gene into a promoterless luciferase reporter vector either in the sense (BP-4-S-PGL) or the antisense (BP-4-AS-PGL) orientation relative to the luciferase (Luc) codon sequence as described in Materials and Methods. The sense (S) and the antisense (AS) plasmids were then transfected into the CaCo-2 cells and the levels of Luc activity (Fig. 5A) . The activity of both the S and AS vectors was negligible in the negative control Swiss 3T3 and WI-38 cell transfectants (the results for Swiss 3T3 cells is shown in Fig. 5A ), confirming the specificity and (Fig. 3) . Nucleotide ϩ1 is indicated by an arrowhead above. Minor initiation sites at nt ϩ6 and ϩ11 are underlined. The putative TATAA element at nt Ϫ18 to Ϫ14 is boxed. The primers used to generate the PCR product for insertion into the luciferase vector are indicated by arrows above the corresponding sequences. An alu repetitive element, spanning nt Ϫ1150 to Ϫ848, is underlined. Potential binding sites for the transcription factors ATF/CREB (nt Ϫ1169 to Ϫ1161), AP-I (nt Ϫ866 to Ϫ859) and Egr-I (nt Ϫ562 to Ϫ554, nt ϩ228 to ϩ235, nt ϩ261 to ϩ269) and Sp1 (nt Ϫ1204 to Ϫ1199, nt Ϫ904 to Ϫ899, nt Ϫ313 to Ϫ305, nt Ϫ72 to Ϫ64, nt ϩ36 to ϩ45, and nt ϩ153 to ϩ159) are indicated. The translation initiation codon begins at nt ϩ285. B, Comparison of the human and rat IGFBP-4 promoter regions is shown. The corresponding region of the rat IGFBP-4 gene (GenBank accession number L08276) was compared with the human sequence listed above using the Bestfit program of the GCG Sequence Analysis Package using the default parameters (49, 50) . Numbering of both sequences is relative to the major transcription initiation site (nt ϩ1).
functionality of the approximately 1.4 kb promoter fragment in CaCo2 cells. The ratio of Luc/␤-Gal activity increased sharply from days 3 and 4 to day 5 and declined rapidly thereafter (data from a representative experiment is shown in Fig. 5B ). The activity of the S vector was significantly higher on days 5 and 6 compared with that on day 4 (Fig. 5B) . In five separate experiments, cells were transfected with either 1 or 5 g of the S vector and 1 g of the ␤-Gal vector as described in the legend of activity increased by approximately 195% on day 5 compared with that on day 3 (arbitrarily assigned a 100% value) (Fig.  5E) . The values on day 5 were significantly higher than the values on either day 3 or day 7 (P Ͻ 0.05) (Fig. 5E) .
To determine if the activity of the 1,254-bp promoter fragment was regulated in a manner similar to the activity of the endogenous IGFBP-4 gene, we analyzed duplicate samples for relative levels of IGFBP-4 mRNA by RT-PCR as described in Materials and Methods. A representative set of autoradiographs from one experiment (of a total of three experiments) is shown in Fig. 6 , A and B. The relative levels of IGFBP-4 mRNA levels in CaCo2 cells on days 3-11 were determined by a radiolabeled RT-PCR reaction for 15-30 cycles as shown in Fig. 6A . The ethidium bromide staining of the reaction products from 32 cycles of PCR reaction is shown in Fig. 6B . The relative levels of IGFBP-4 RNA measured by either of the two methods from the five different cycles of PCR reaction gave essentially similar results (Fig. 6C) . In each case, we observed a significant increase in the relative levels of IG-FBP-4 mRNA on days 5 and 6 compared with that on day 4, which closely resembled the pattern of promoter activity measured in the cells transfected with the sense IGFBP-4 vector (Fig. 5B) . Relative levels of endogenous IGFBP-4 RNA on different days of culture, from three experiments, are presented as a % change in Fig. 6D , wherein the values on day 4 were arbitrarily assigned a 100% level. The activity of the promoter fragment on days 3, 5, and 7 ( Fig. 5E ) followed a pattern similar to the relative levels of IGFBP-4 RNA in the CaCo2 cells on different days of culture (Fig. 6D) . Cells growing under similar experimental conditions demonstrated an initial logarithmic growth between days 3 and 6, followed by a rapid decline in the growth of the cells by day 7. The cells demonstrated a plateau phase of growth between days 7-11 ( Fig. 6E) . In one experiment, we also measured the levels of the differentiation marker, alkaline phosphatase, by our published procedures (17) on days 3, 5, and 7. The results of the experiment confirmed our previous report (17) that the ALP activity (differentiation) was minimal on days 3 and 5 and increased significantly by day 7 of culture in association with the plateau (confluent) phase of growth. The results of the present study thus suggest that the approximately 1.4-kb promoter fragment sequenced by us contains the required cis elements that are responsible for the up-and down-regulation of the promoter activity in relation to the growth and differentiation of CaCo2 cells in culture.
Discussion
In the present report, we have for the first time described the cloning and partial characterization of the functional The major start site of transcription was determined by primer extension analysis to be 284 nucleotides 5Ј to the start site of translation. A single transcriptional start site is similarly located in the rat IGFBP-4 gene, 249 nucleotides upstream of the translational initiation ATG codon (26) . A 2.2-kb transcript is the major transcript for the human IG-FBP-4 gene in colon cancer cells including the CaCo2 cells (2, 17) . It thus appears likely that the transcription of the 2.2-kb transcript is initiated at the cap site identified in the 5Ј flanking region of the human IGFBP-4 gene in the present study. In previous studies, we and others have reported a significant regulation of IGFBP-4 mRNA levels in relation to growth and differentiation of the CaCo2 cells in culture (17, 27, 28) . By Northern blot analysis, we observed a significant increase in the relative levels of IGFBP-4 mRNA in CaCo2 cells on days 5-7 of cell culture by approximately 200% compared with that on day 2, followed by a rapid decline in the levels of IGFBP-4 mRNA by days 9 -13 (17) . In the present study, we analyzed the relative levels of IGFBP-4 mRNA by radiolabeled RT-PCR (due to limited availability of RNA samples from cells growing in 35-mm cell culture dishes used in the current studies) and obtained essentially similar results. The relative levels of IGFBP-4 mRNA increased significantly from day 3 to days 5 and 6 and were approximately 150 -250% higher compared with that on days 3 and 4. The IGFBP-4 mRNA levels declined rapidly thereafter, reaching very low levels by days 7-11 of culture. An important observation was that the transcriptional activity of the approximately 1.4 kb hIGFBP-4 promoter, measured in transient transfection assays, was significantly higher on day 5 of cell culture compared with that on days 3 and 7, mirroring the pattern of endogenous IGFBP-4 mRNA expression. Because the pattern of promoter activity closely resembled the pattern of mRNA expression by the endogenous IGFBP-4 gene, it is possible that the cis elements required for transcriptional activation (on day 5 of cell culture) and perhaps transcriptional deactivation (on days 7-9 of cell culture) are present in the 1.4 kb 5Ј flanking region of the IGFBP-4 gene. Our present and previous (17) studies also suggest that endogenous factors required for the up-regulation of the transcriptional activity of the IGFBP-4 gene and of the approximatley 1.4 kb promoter fragment are probably available to the cells in a cell density-dependent manner (wherein cells undergoing rapid proliferation at approximately 50 -60% confluency provide the initial cues for activation of the IGFBP-4 gene/ promoter). Under the culture conditions of the present study the growth pattern of the cells was almost identical to that published by us previously (17) , wherein the cells demonstrated a rapid growth phase between days 2 and 7 of cell culture followed by a plateau phase of growth associated with cell confluence. We have previously reported that the cells are minimally differentiated during the rapid phase of CaCo2 cell growth between days 2-7 and undergo rapid differentiation in postconfluent cells between days 7-13 (17) .
Under the cell culture conditions of the present study, we similarly observed a significant increase in the differentiation of the cells by day 7 of culture (with negligible differentiation at earlier time points). Thus, a significant increase in the transcriptional activation of the 1.4 kb IGFBP-4 promoter and the endogenous IGFBP-4 gene preceded the on set of rapid differentiation of CaCo2 cells in culture. We therefore speculate that transcriptional activation of IGFBP-4 gene is perhaps an important physiological event that may be required for the rapid on set of differentiation by colonocytes in culture. It is possible that endogenous factors required for transcriptional activation of IGFBP-4 gene are perhaps regulated in a cell density-dependent manner that may be importantly involved in setting up the chain of events culminating in the differentiation of the enterocytes.
The concentration of several IGFBPs (including IGFBP-4) has been reported to significantly increase in the atretic follicles of ovaries from many species (29 -31) , suggesting that the increase in the availability of the inhibitory IGFBPs (especially IGFBP-4) plays an equally important role in apoptosis (29) . Recent evidence suggests that a significant decrease in the proteolytic activity of IGFBP-4 may play a major role in up-regulating the levels of IGFBP-4 protein in the atretic follicles (30, 31) ; it remains to be determined if transcriptional activation of IGFBP-4 also plays a role in regulating the availability of IGFBP-4 (and hence IGFs) in the developing and atretic follicles, as suggested by some investigators (29) . Thus, transcriptional activation/deactivation of IGFBP-4 gene may play an important role in the growth, differentiation, and apoptosis of epithelial cells in different tissues/organs. While the present studies were not designed to investigate the endogenous factors that may be involved in the transcriptional activation of the IGFBP-4 gene, the cloning and sequencing of the functional promoter for the IGFBP-4 gene has provided us for the first time with some important clues with respect to the possible nature of these factors as discussed below.
The approximately 1.45 kb human IGFBP-4 promoter sequence (5Ј to the initiation ATG codon) demonstrated only 74% homology to the corresponding rat IGFBP-4 promoter sequence (Fig. 4B) . On sequence analysis of the 5Ј flanking region of the hIGFBP-4 gene, a TATA box consensus sequence was revealed 14 bp upstream of the major start site of transcription (present study). In the rat IGFBP-4 gene, the TATA box is located 27 bp upstream of the start site of transcription (26) . The 1,254 bp 5Ј flanking region of the human IGFBP-4 gene lacked a CAAT box, a common regulatory element, which was reported to be located at nucleotides Ϫ100 to Ϫ106 in the rat IGFBP-4 gene (26) . The location and number of the potential cis elements identified in the 5Ј flanking region of the human IGFBP-4 gene (present study) were also different from that identified in the corresponding region of the rat IGFBP-4 gene (26) . Computer analysis of the 1,467-bp DNA segment, 5Ј to the translational initiation ATG codon, revealed several potential binding sites for transcription factors in the hIGFBP-4 promoter. Potential ATF/CREB (Ϫ1169 to Ϫ1161) and AP-I (Ϫ866 to Ϫ859) binding sites were located upstream from the promoter. Three sequences (Ϫ562 to Ϫ554; ϩ228 to ϩ235; ϩ261 to ϩ269) matching the early growth response factor I (Egr-I) binding site were found. Numerous potential SPI binding sites were present in the GC rich region of the human IGFBP-4 promoter. In the promoter region of the rat IGFBP-4 gene, on the other hand, at least three potential cAMP response elements (CRE) were located Ϫ360 to Ϫ353, Ϫ831 to Ϫ824, and Ϫ1264 to Ϫ1257, and three putative AP-I binding sites were located at nucleotides Ϫ156 to Ϫ150, Ϫ371 to Ϫ365, and Ϫ1388 to Ϫ1382 (26). Based on of cells)/dish. RNA samples from CaCo2 cells growing in culture for days 3-11 were subjected to RT-PCR for 15-32 cycles, using the primers specific for hIGFBP-4 cDNA, in the presence or absence of radiolabeled dCTP, as described in Materials and Methods. A, The radiolabeled PCR products, amplified for 15-30 cycles, were autoradiographically developed and the data from a representative experiment (of a total of three experiments) is shown. B, The ethidium bromide staining of the reaction products from 32 cycles of PCR is shown. C, The density of the bands, relative to the density of the day 4 band (arbitrarily assigned a value of 1.0), is presented for samples amplified for 15-32 cycles. As can be seen from Fig. 6C , the relative density of the day 5 and 6 samples was increased approximately 180 to Ͼ200% compared with the density of the day 4 samples after PCR amplification for 15 to 32 cycles. D, The relative density of the PCR products from the five different cycles are also presented as a % change, wherein the day 4 readings were arbitrarily assigned a 100% value. Each bar represents mean Ϯ SEM of the relative density values (shown in C) measured for the five cycles on days 3-11. *, P Ͻ 0.05 vs. day 4 readings. As can be seen from Fig. 6D , the relative levels of IGFBP-4 mRNA were significantly higher at days 5 and 6 compared with that on day 4. E, In duplicate dishes the total number of cells/dish were counted on different days in culture and the results are shown in E. Each data point represents the mean of two to three observations/experiment. The intraexperimental variation for each data point was less than 5-10%. this information, even though the specific location and number of potential cAMP response elements and AP-I binding sites were different in the human and the rat IGFBP-4 gene promoter, it appears likely that agents that increase or decrease the levels of intracellular cAMP and/or protein kinases A and C can potentially regulate the transcription of both the rat and the human IGFBP-4 gene. In several human and rat cell types mRNA levels of IGFBP-4 have been reported to be increased in response to treatment with dibutyryl cAMP or agents that are known to increase intracellular levels of cAMP (32) (33) (34) . Similarly, IGFBP-4 mRNA levels were significantly increased in response to PTH in SaOS-2 human osteoblasts (35) and in response to forskolin (cAMP agonist) in the TC-1 human bone marrow stromal cells (36) . It is therefore possible that the single cAMP response element (ATF/CREB binding site), identified in the 1.4-kb human IGFBP-4 promoter sequence, may be a functional cis element required for the transcriptional activation of the IGFBP-4 promoter by endogenous factors in CaCo2 cells. The consensus octameric cAMP-response element TGACGTCA (CRE) and the heptameric phorbol ester-responsive element TGACTCA (TRE) are similar but are differentially regulated by cAMP and phorbol esters such as TPA (reviewed in 37). While cAMP can stimulate the transcriptional activation of promoters containing the CRE and the TRE elements, TPA has little effect on CRE containing promoters but regulates the transcriptional activity of TRE containing promoters (reviewed in Ref. 37 ). The potential ATF/CREB binding site identified in the human IGFBP-4 gene by computer analysis (GTGACGACC) bears a higher homology with the CRE cis element than with the consensus TRE element.
An AP-I binding site was identified as the second common cis element in the human and the rat IGFBP-4 promoter sequence (Fig. 4A) . In the human IGFBP-4 promoter sequence, a single AP-I binding site, bearing an almost 100% homology to the consensus AP-I binding sequence (TGAG/ CTCA, 38), was located Ϫ870 to Ϫ859 upstream from the start site of the promoter. Several nuclear proteins including c-fos, c-jun, and related gene products have been identified as a part of the AP-I protein complex that binds the AP-I site (reviewed in 38). These complexes apparently possess both transcriptional activation and repression properties as per the reported transient transfection assay studies (reviewed in Ref. 38) . At the present time, the role of transcriptional factors that bind the AP-I binding site in regulating the mRNA levels for IGFBP-4 is not known. The cis element CRE is related to several AP-I binding sites, but the nuclear proteins CREB/ ATF bind the AP-I sites with significantly lower affinity than to the CRE sites (38) . It thus remains to be seen if the single AP-I binding site identified so far in the human IGFBP-4 promoter sequence is required for transcriptional activation (or repression) of the promoter. Further studies with truncated and mutated promoter sequences will help us to answer this question.
As per current knowledge, IGFs do not appear to have a direct role to play in the transcriptional regulation of IGFBP-4 mRNA levels but are mainly involved in the post-translational regulation of IGFBP-4 levels by enhancing the proteolytic degradation of IGFBP-4 in the conditioned media of cells that are secreting specific proteolytic enzymes (39 -42).
In vascular smooth muscle cells, a significant increase in the level of IGFBP-4 mRNA was reported in a cell density-dependent manner, which was unaffected by IGF-I treatment (42) . It thus appears unlikely that IGF-II functions as the endogenous regulator of the transcriptional activity of IG-FBP-4 promoter in CaCo2 cells. Endogenous factors other than IGFs are perhaps responsible for the transcriptional activation of the IGFBP-4 promoter in a cell density (proliferative vs. differentiation?)-dependent manner.
1,25-dihydroxyvitamin D 3 (43) , retinoic acid (RA), and estrogens (44) are a few other agents that have been examined for their effect on the IGFBP-4 expression levels. All three steroidal agents were reported to elevate the levels of IGFBP-4 mRNA in either human osteosarcoma cells (43) or estradiol receptor positive human breast cancer cells (44) . Steroid response elements that can bind receptors for vitamin D 3 , RA, or estrogens, however, were not identified in the approximately 1.4 kb 5Ј flanking promoter sequences of either the human IGFBP-4 gene (present study) or the rat IGFBP-4 gene (26) . It remains possible that enhancer elements 5Ј to the 1.4 kb promoter sequence are present in the human and the rat IGFBP-4 genes. A sequence TGTTCACT, identical to the progesterone receptor binding site in the uteroglobin gene (45) , was identified in the rat IGFBP-4 promoter region (26) . The 1,254-bp promoter region (5Ј of the cap site of the human IGFBP-4 gene), however, was devoid of a progesterone receptor binding element (present study). It is possible that a progesterone receptor binding site is present further upstream in the human IGFBP-4 gene promoter, but its role in transcriptional regulation of IGFBP-4 gene in human colon cancers is questionable since human colon cancers are not known to express the progesterone receptor (46, 47) .
Interestingly, at least three sequences closely matching the early growth response factor-I binding site were found in the human IGFBP-4 5Ј flanking promoter region; similar sequences are also present in the rat IGFBP-4 gene (as per computer analysis of the rat IGFBP-4 promoter sequence published by Gao et al., 26) . Egr-I belongs to a family of transcription factors, such as c-fos and c-jun, that are rapidly induced as a first step in response to several mitogens including growth factors and the tumor promoter, TPA (reviewed in Ref. 48) . Extracellular stimuli that induce Egr-I also include developmental or differentiation cues in some cell types. In several cell types, a rise in Egr-I expression is correlated with differentiative processes (reviewed in Ref. 48 ). For example, RA induces differentiation of osteoblasts in relation to a rapid induction of Egr-I, suggesting a role for Egr-I in differentiation of the osteoblastic cells (reviewed in Ref. 48 ). Egr-I expression has been demonstrated to be necessary for differentiation of the myeloid cells along the macrophage lineage (48) . A role of Egr-I expression in the differentiation of colonic epithelial cells is unknown. In the present study at least one Egr-I binding site (Ϫ562 to Ϫ554) was included in the promoter segment used in the transient transfection studies with the IGFBP-4 promoter-LUC expression vector. It remains to be determined if the Egr-I binding site played a role in either transcriptional activation (at day 5 of cell culture) or deactivation (at days 7-9 of culture) of the IGFBP-4 promoter in CaCo2 cells. Because Egr-I can be potentially induced both in response to growth factors and in relation to differentiation, it is possible that the Egr-I binding sites in the IGFBP-4 gene may play a role in the transcriptional regulation of the gene both during the proliferative and the differentiation phases of the CaCo2 cell growth in culture.
Thus, the cloning and sequencing of the human IGFBP-4 promoter that apparently contains the cis elements required for transactivation and deactivation, in a manner similar to the expression profile of the endogenous gene, provides a valuable tool for investigating the specific endogenous (cell density-dependent?) factors that may be required for regulating the transcriptional activity of the hIGFBP-4 gene in colonocytes.
